• FirefoxTry Yahoo Finance on Firefox »
  •  Dow up 1.23% Nasdaq up 1.74%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
     Dow up 1.23% Nasdaq up 1.74%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

    Quote Results

    Add Quotes

    SymbolTime & PriceChg & % ChgDay's Low & HighVolumeAvg VolMkt CapChartMore Info
    Oct 2 75.93 +1.04 +1.39% 75.21 76.01 6,149 10,598 239.48B Sparkline Chart Chart, News, Stats, Board
    No such ticker symbol: HBCYF.LTry Symbol Lookup
    - 90.88 0.00 0.00% - - 104 35,267 219.49B Sparkline Chart Chart, News, Stats, Board
    Oct 2 266.74 +2.33 +0.88% 263.11 266.74 213 3,127 227.07B Sparkline Chart Chart, News, Stats, Board
    No such ticker symbol: VODPF.LTry Symbol Lookup
    No such ticker symbol: 7203Try Symbol Lookup
    No such ticker symbol: BPAQF.LTry Symbol Lookup
    No such ticker symbol: RYDAF.LTry Symbol Lookup
    Oct 2 84.98 +0.37 +0.44% 83.47 86.26 3,170,361 3,251,757 111.41B Sparkline Chart Chart, News, Stats
    {"s" : "nsrgf,nvsef,rhhvf,san.pa","k" : "t53,l84,c63,p43,g53,h53,v53,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

    Quotes delayed, except where indicated otherwise.

    Recent News

    day and time symbols news headline and source
    Friday October 2, 2015
    XOMA Shoots up on Immuno-Oncology Deal with Novartis Zacks06:21pm EDT
    Amgen Is In Novartis' Crosshair at Motley Fool12:03pm EDT
    Novartis biosimilar copycat takes aim at Amgen's drug Enbrel Reuters03:31am EDT
    Thursday October 1, 2015
    Working in-house becomes an exciting option for lawyers at Financial Times07:02pm EDT
    Law firms implement tactics to level the playing field at Financial Times07:02pm EDT
    Novartis Announces Positive Data on Arthritis Drug Cosentyx Zacks05:50pm EDT
    One way Genentech hopes to stop cancer, other diseases in their tracks at American City Business Journals05:00pm EDT
    MannKind Cuts Its Headcount, But Will It Matter? at Motley Fool01:35pm EDT
    Sanofi Announces Launch of Authorized Generic Version of Arava® (Leflunomide) Tablets PR Newswire08:55am EDT
    Xoma enters exclusive license agreement with Novartis at MarketWatch07:46am EDT
    Alnylam and Genzyme Announce that Genzyme Opts into ALN-AT3 Hemophilia Program for Development and Commercialization Outside of North America and Western Europe Business Wire07:00am EDT
    High-end Swiss chocolate brand to finally hit U.S. at USA TODAY12:28am EDT
    Wednesday September 30, 2015
    Sanofi’s Profitability Improved in 2Q15 Market Realist06:06pm EDT
    Roche Presents Positive Data on Respiratory Drug Esbriet Zacks05:35pm EDT
    How Did Sanofi Pasteur Perform in 2Q15? Market Realist05:06pm EDT
    Express Scripts says Praluent, Repatha will not be "budget busters" Reuters04:10pm EDT
    Other Sanofi Franchises that Drove Pharmaceutical Growth in 2Q15 Market Realist04:06pm EDT
    Nestle seeks increased global sales of Cailler premium chocolate Reuters03:45pm EDT
    Here’s what Wall Street isn’t telling you about this stock market at MarketWatch09:24am EDT
    This Cancer Immunotherapy News Is Going to Turn Some Heads at Motley Fool08:42am EDT
    Novartis CEO: Here's How We'll Get Cheap Medicine To Poor Countries at Forbes08:34am EDT
    Nestle's Cantarell Sees Promise in Russia Amid Economic Doldrums at Bloomberg05:15am EDT
    Tuesday September 29, 2015
    Sanofi, Eli Lilly Agree to Settle Lantus Patent Litigation Zacks04:55pm EDT
    Diabetic Investor On MannKind: 'There's A Reason Why So Many People Are Short This Stock' Benzinga03:11pm EDT
    Regeneron Pharmaceuticals and Sanofi Grab Another Important Win at Motley Fool09:10am EDT